Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Collier, D A
Milovancevic, M P
Schulze, T G
Nöthen, M M
Morris, D W
Moyzis, R K
MetadataShow full item record
CitationMol. Psychiatry 2014, 19 (7):774-83
AbstractGenes that are differentially expressed between schizophrenia patients and healthy controls may have key roles in the pathogenesis of schizophrenia. We analyzed two large-scale genome-wide expression studies, which examined changes in gene expression in schizophrenia patients and their matched controls. We found calcium/calmodulin (CAM)-dependent protein kinase kinase 2 (CAMKK2) is significantly downregulated in individuals with schizophrenia in both studies. To seek the potential genetic variants that may regulate the expression of CAMKK2, we investigated the association between single-nucleotide polymorphisms (SNPs) within CAMKK2 and the expression level of CAMKK2. We found one SNP, rs1063843, which is located in intron 17 of CAMKK2, is strongly associated with the expression level of CAMKK2 in human brains (P=1.1 × 10(-6)) and lymphoblastoid cell lines (the lowest P=8.4 × 10(-6)). We further investigated the association between rs1063843 and schizophrenia in multiple independent populations (a total of 130 623 subjects) and found rs1063843 is significantly associated with schizophrenia (P=5.17 × 10(-5)). Interestingly, we found the T allele of rs1063843, which is associated with lower expression level of CAMKK2, has a higher frequency in individuals with schizophrenia in all of the tested samples, suggesting rs1063843 may be a causal variant. We also found that rs1063843 is associated with cognitive function and personality in humans. In addition, protein-protein interaction (PPI) analysis revealed that CAMKK2 participates in a highly interconnected PPI network formed by top schizophrenia genes, which further supports the potential role of CAMKK2 in the pathogenesis of schizophrenia. Taken together, these converging lines of evidence strongly suggest that CAMKK2 may have pivotal roles in schizophrenia susceptibility.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
- A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.
- Authors: Atakhorrami M, Rahimi-Aliabadi S, Jamshidi J, Moslemi E, Movafagh A, Ohadi M, Mirabzadeh A, Emamalizadeh B, Ghaedi H, Gholipour F, Fazeli A, Motallebi M, Taghavi S, Ahmadifard A, Mohammadihosseinabad S, Shafiei Zarneh AE, Shahmohammadibeni N, Madadi F, Andarva M, Darvish H
- Issue date: 2016 Mar
- Association analysis between CAMKK2 rs1063843 and patients with schizophrenia in a Han Chinese population.
- Authors: Qian L, Zhou D, Zhang F, Chen X, Yang B, Dong K, Wang Z, Zhang K
- Issue date: 2020 Aug
- Effect of rs1063843 in the CAMKK2 gene on the dorsolateral prefrontal cortex.
- Authors: Yu P, Chen X, Zhao W, Zhang Z, Zhang Q, Han B, Zhai J, Chen M, Du B, Deng X, Ji F, Wang C, Xiang YT, Li D, Wu H, Li J, Dong Q, Chen C
- Issue date: 2016 Jul
- Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.
- Authors: Yang MS, Morris DW, Donohoe G, Kenny E, O'Dushalaine CT, Schwaiger S, Nangle JM, Clarke S, Scully P, Quinn J, Meagher D, Baldwin P, Crumlish N, O'Callaghan E, Waddington JL, Gill M, Corvin A
- Issue date: 2008 Jul 15
- Impact of Genetic Variation on Human CaMKK2 Regulation by Ca<sup>2+</sup>-Calmodulin and Multisite Phosphorylation.
- Authors: O'Brien MT, Oakhill JS, Ling NX, Langendorf CG, Hoque A, Dite TA, Means AR, Kemp BE, Scott JW
- Issue date: 2017 Feb 23